APOE genotype influences triglyceride and C-reactive protein responses to altered dietary fat intake in UK adults

2002, Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report, Circulation, 106, 3143, 10.1161/circ.106.25.3143 Scientific Advisory Committee on Nutrition and Committee on Toxicology. Advice on fish consumption: benefits and risks: TSO. Norwich, UK: The Stationary Office, 2004. Kris-Etherton, 2002, Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease, Circulation, 106, 2747, 10.1161/01.CIR.0000038493.65177.94 Jebb, 2010, Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial, Am J Clin Nutr, 92, 748, 10.3945/ajcn.2009.29096 Caslake, 2008, Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study, Am J Clin Nutr, 88, 618, 10.1093/ajcn/88.3.618 Song, 2004, Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease, Ann Intern Med, 141, 137, 10.7326/0003-4819-141-2-200407200-00013 Bennet, 2007, Association of apolipoprotein E genotypes with lipid levels and coronary risk, JAMA, 298, 1300, 10.1001/jama.298.11.1300 Masson, 2003, Genetic variation and the lipid response to dietary intervention: a systematic review, Am J Clin Nutr, 77, 1098, 10.1093/ajcn/77.5.1098 Minihane, 2007, ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation, Proc Nutr Soc, 66, 183, 10.1017/S0029665107005435 Leigh-Firbank, 2002, Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses, Br J Nutr, 87, 435, 10.1079/BJN2002556 Wei, 2011, Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis, Curr Atheroscler Rep, 13, 474, 10.1007/s11883-011-0210-3 Olano-Martin, 2010, Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil, Atherosclerosis, 209, 104, 10.1016/j.atherosclerosis.2009.08.024 Minihane, 2000, ApoE polymorphism and fish oil supplementation in subjects with an antherogenic lipoprotein phenotype, Arterioscler Thromb Vasc Biol, 20, 1990, 10.1161/01.ATV.20.8.1990 Lockyer S, Tzanetou M, Carvalho-Wells AL, Jackson KG, Minihane AM, Lovegrove JA. SATgenε dietary model to implement diets of differing fat composition in prospectively genotyped groups (apoE) using commercially available foods. Br J Nutr 2012; Jun 16:1–9. Edelstein, 1986, Precautionary measures for collecting blood destined for lipoprotein isolation, Methods Enzymol, 128, 151, 10.1016/0076-6879(86)28065-9 Brady, 2004, Revised QUICKI provides a strong surrogate estimate of insulin sensitivity when compared with the minimal model, Int J Obes Relat Metab Disord, 28, 222, 10.1038/sj.ijo.0802547 Tierney AC, McMonagle J, Shaw DI, Gulseth HL, Helal O, Saris WH, Paniagua JA, Gołąbek-Leszczyñska I, Defoort C, Williams CM, et al. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome-LIPGENE: a European randomized dietary intervention study. Int J Obes (Lond) 2011; 35: 800 – 9. Mensink, 2003, Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials, Am J Clin Nutr, 77, 1146, 10.1093/ajcn/77.5.1146 Loktionov, 2000, Gene-nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E epsilon4-carrying free-living individuals, Br J Nutr, 84, 885, 10.1017/S0007114500002506 Wu, 2007, Apolipoprotein E polymorphisms, dietary fat and fibre, and serum lipids: the EPIC Norfolk study, Eur Heart J, 28, 2930, 10.1093/eurheartj/ehm482 Campos, 2001, Gene-diet interactions and plasma lipoproteins: role of apolipoprotein E and habitual saturated fat intake, Genet Epidemiol, 20, 117, 10.1002/1098-2272(200101)20:1<117::AID-GEPI10>3.0.CO;2-C Tikkanen, 1990, Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet, Arteriosclerosis, 10, 285, 10.1161/01.ATV.10.2.285 Sarkkinen, 1998, Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol, Am J Clin Nutr, 68, 1215, 10.1093/ajcn/68.6.1215 Harris, 1997, n-3 fatty acids and serum lipoproteins: human studies, Am J Clin Nutr, 65, 1645S, 10.1093/ajcn/65.5.1645S Dong, 1996, Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins, J Biol Chem, 271, 19053, 10.1074/jbc.271.32.19053 Heeren, 2006, Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis, Arterioscler Thromb Vasc Biol, 26, 442, 10.1161/01.ATV.0000201282.64751.47 Jakobsen, 2009, Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies, Am J Clin Nutr, 89, 1425, 10.3945/ajcn.2008.27124 Kaptoge, 2010, C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis, Lancet, 375, 132, 10.1016/S0140-6736(09)61717-7 Petersson, 2010, Effects of dietary fat modification on oxidative stress and inflammatory markers in the LIPGENE study, Br J Nutr, 104, 1357, 10.1017/S000711451000228X King, 2003, Relation of dietary fat and fiber to elevation of C-reactive protein, Am J Cardiol, 92, 1335, 10.1016/j.amjcard.2003.08.020 King, 2003, Relation of dietary fat and fiber to elevation of C-reactive protein, Am J Cardiol, 92, 1335, 10.1016/j.amjcard.2003.08.020 Myhrstad, 2011, Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors, Inflamm Res, 60, 309, 10.1007/s00011-010-0302-5 März, 2004, The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study), Eur Heart J, 25, 2109, 10.1016/j.ehj.2004.08.024